
ãã€ãã«ãLancetèªãmRNA COVIDã¯ã¯ãã³ããèªç¶å ç«ã®æ¹ãåªããŠããããšãèªãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
Lancetèªã«æšææ¥ã«çºè¡šãããç ç©¶ã«ãããšãCOVID-19ã®éå»ã®ææã§ç²åŸããå ç«ã«ããããã®ç æ°ã«ããæ·±å»ãªçµæã«å¯ŸããŠãmRNAã¯ã¯ãã³ã«ãããã®ãšãåçããã以äžã®ãã¬ãã«ã§åŒ·åãã€æç¶çãªä¿è·ãåŸãããããšãæããã«ãªã£ãã
ç ç©¶è ãã¡ã¯ãäžçäžã§è¡ããã65ã®ç ç©¶ã®ç³»çµ±çã¬ãã¥ãŒãšã¡ã¿åæãè¡ããå€ãã®ç§åŠè ãå»åž«ãç ç©¶ãCOVID-19ã®æµè¡åæããè¿°ã¹ãŠããããšãæ¯æããå§åçãªèšŒæ ãæäŸããã®ã§ãã
ãã©ã³ã»ããã¯ãå»åž«ãç§åŠè ãé·å¹Žèšã£ãŠããããšãã€ãŸãèªç¶å ç«ã®æ¹ãå®éšçã¯ã¯ãã³ããåªããé²åŸ¡ãæäŸãããšããããšãã€ãã«èªããã®ã§ãããšãChildren's Health Defenseã®äŒé·å Œäž»ä»»èšŽèšåŒè·å£«ãããŒãã»Fã»ã±ããã£Jr.ã¯èšãã
ã補è¬äŒç€ŸïŒæ¿åºã®ãã€ãªã»ãã¥ãªãã£ãŒã«ã«ãã«ãšã³ã³ãããŒã«ãããã¡ãã£ã¢ããã®ãããã¬ã³ããšæ€é²ã®æŽ¥æ³¢ã ããããã¡ã€ã¶ãŒãšã¢ãã«ããç¥ãé²åããã人éã®å ç«ã·ã¹ãã ãå®ãã®ã«åªããŠãããšäžè¬å€§è¡ã説åŸããã®ã§ãããšåœŒã¯ä»ãå ããŸããã
ãã®ç ç©¶ã§ã¯ãææã«ãã£ãŠç²åŸãããå ç«ã®æ¹ããmRNAã¯ã¯ãã³ã2åæäžããå Žåã®å ç«ããããã¯ããã«åŒ·åºã§ãäžè²«ããŠè¡°ããé ãããšãåãã£ãã
ç ç©¶è ãã¯ãèªç¶å ç«ã¯ãææãã10ã«æåŸããã¹ãŠã®COVID-19äºçš®ã«å¯ŸããŠãå°ãªããšã88.9%ã®éçåãå ¥é¢ãæ»äº¡ã«å¯Ÿãã广ãããããšãèŠãã ããã
ãŸããåææã«å¯Ÿããé²åŸ¡çã¯ã45.3ïŒ ã§ãã£ãomicron BA.1ãé€ããã¹ãŠã®äºçš®ã§78.6ïŒ ã§ãããåææãé²ãããšãã§ããŸããã
2022幎10æã®ç±³åœçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒäºé²æ¥çš®å®æœè«®åå§å¡äŒã§ãCDCã¯ã2ïœ3åæ³šå°åŸã®ã¯ã¯ãã³ç²åŸå ç«ã泚å°åŸ6ã«æã§ãŒãã«ãªãããã®åŸãã€ãã¹ã«ãªããšããããŒã¿ãçºè¡šããŸããã
Lancetèªã®ç ç©¶ã§ã¯ãããã¹ãŠã®äºçš®ããã®åææããã®é²åŸ¡ã¯æéãšãšãã«è¡°ããããå©çšå¯èœãªããŒã¿ã®åæããã以åã®ææã«ãã£ãŠäžããããé²åŸ¡ã¬ãã«ã¯ãé«å質ã®mRNAã¯ã¯ãã³ïŒModernaããã³Pfizer-BioNTechïŒãçšãã2åæ¥çš®ã«ãã£ãŠåŸããããã®ãšåçããã以äžã§ããããšã瀺ããããããšè¿°ã¹ãããŠããŸãã
ãã®ç ç©¶ã¯ããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ããäžéšè³éæäŸãåããŠããŸãããã®ç ç©¶æã¯ããCOVIDãã³ãããã¯éå§æã«ãCOVIDã«ããæ»äº¡ã20åãé倧è©äŸ¡ããæªåé«ãèªåŒµæ»äº¡çèšç®ã«å€§ããé¢äžãããã±ããã£ã«ããã°ãã²ã€ã財å£ãåºè³ããŠããç ç©¶æã§ããã
èè ãã¯ãä»åã®èª¿æ»çµæã«åºã¥ããŠãåœå±ãäºé²æ¥çš®ã®ç¶æ³ã«åºã¥ããŠæ è¡ãäŒå Žãžã®ã¢ã¯ã»ã¹ãä»äºã®å¶éãæ€èšããéã«ã¯ãã¯ã¯ãã³ãšãšãã«èªç¶å ç«ãèªèãã¹ãã ãšäž»åŒµããã
ãããã®çµè«ã«ã€ããŠãå ç§å»ã§ç«åŠè ã®Meryl Nasså士ã¯ã次ã®ããã«è¿°ã¹ãŠããŸãã
ãèªç¶å ç«ã«ããäºé²ãèªããŠããããã«èŠããããŠãæ¿åºã«ããæž¡èªå¶éæ¿çã容èªãããããšãæé»ã®äºè§£ãšããŠããã®ã§ããããã«ãã¯ã¯ãã³ãã¹ããŒããé»èªããŠããã®ã§ãã
èªç¶å ç«ã«å¯Ÿãããã«ã«ãã«ãã®æŠäº
2020幎10æãLancetèªã¯ãCDCé·å®ã®Rochelle Walenskyãå«ãèè ã«ããè«æ-ãCOVID-19ãã³ãããã¯ã«é¢ããç§åŠçåæïŒæã ã¯ä»ããè¡åããå¿ èŠãããã-ãæ²èŒããäž»èŠçŽã§å€§ããåãäžããããŸããã圌ãã¯ããèªç¶ææåŸã®SARS-CoV-2ã«å¯Ÿããæç¶çãªé²åŸ¡å ç«ã瀺ã蚌æ ã¯ãªã ããšãããå ç«ãè¡°ãããšããçµæã¯ãç¡æéã«è匱ãªéå£ã«ãªã¹ã¯ãããããã ãã ããšè¿°ã¹ãŠããŸãã
ãããã2021幎11æãæ å ±å ¬éæ³ïŒFOIAïŒã®èŠè«ã«ãããCDCã¯èªç¶å ç«ã®ããŒã¿ããåéããŠããªãããšãèªããããåŸãªããªã£ãã
ãããŠ2022幎1æãCDCã¯èªç¶å ç«ã«é¢ããèŠè§£ãä¿®æ£ããããåŸãªããªããCOVID-19ã«å¯Ÿããèªç¶å ç«ã«ã¯ããã«ã¿å€çš®ãžã®ææãé²ã广ãã¯ã¯ãã³æ¥çš®ã®å°ãªããšã3åããããšãå ±åæžã§èªããã
補è¬äŒç€Ÿãããã®æ å ±ãæå§ããŠãããã®ã®ãèªç¶å ç«ã®å¹æãèªèããŠããããšãææžã§æããã«ãªã£ãã
2021幎10æãProject Veritasã¯ããã¡ã€ã¶ãŒã®3人ã®é¢ä¿è ããæäœã¯ã¯ã¯ãã³ãšæ¯èŒããŠããŠã€ã«ã¹ã«å¯Ÿããããè¯ãä¿è·ã«ã€ãªãããªããŸã§ããåçã®ä¿è·ã«ã€ãªãããšèšã£ãŠããããšãæŽé²ãããšãThe Defenderã¯å ±ããŠããã
ãã®åŸã2022幎4æã«ã¯ãç±³åœé£åå»è¬åå±ïŒFDAïŒãä¿æããè£å€æã®åœä»€ã§å ¬éããããã¡ã€ã¶ãŒç€Ÿã®ææžããããã¡ã€ã¶ãŒç€Ÿãèªç¶å ç«ãå瀟ã®COVID-19ã¯ã¯ãã³ãšåæ§ã«éçå鲿¢ã«æå¹ã§ããããšãç¥ã£ãŠããããšã確èªãããšããžã£ãŒããªã¹ãã®ãã ã»ã¢ã€ããŒã»ã³æ°ã¯å ±åããã
æè¿ã§ã¯ãFDAã®ããããåããŠãããã¡ã€ã¶ãŒç€Ÿã®åœ¹å¡ããèªç¶å ç«ãCOVID-19ã¯ã¯ãã³æ¥çš®ããåªããŠããããšãæ£ç¢ºã«ææããæçš¿ã«å¯ŸããŠããã€ãã¿ãŒã«åããããŠããããšããã€ãã¿ãŒã®ãã¡ã€ã«ããæããã«ãªã£ããšãšããã¯ã¿ã€ã ãºçŽã¯å ±ããŠããã
ãŸããã¢ã³ãœããŒã»ãã¡ãŠãå士ãšãã®äžåžã§ãããã©ã³ã·ã¹ã»ã³ãªã³ãºåœç«è¡çç ç©¶ææé·ãçµèšããŠãCOVID-19ã«ããå ¬è¡è¢«å®³ã軜æžããããã«èªç¶å ç«ãéèŠãªåœ¹å²ãæãããšäž»åŒµãããã°ã¬ãŒãã»ããªã³ãã³å®£èšãã匟å§ããããšããæ å ±å ¬éè«æ±ã«ããæããã«ãªã£ããšThe Defenderã¯å ±ããŠããã
ã¯ã¯ãã³ã倱æããŠãããã€ãŸããã£ãšã¯ã¯ãã³ãå¿ èŠãªã®ã
ãã®ç ç©¶ãå ±ããNBCãABCãU.S. News & World Reportãªã©ã®ã¡ãã£ã¢ã¯ãCOVID-19ã«ããéçåãæ»äº¡ããå®ãã«ã¯ã¯ã¯ãã³æ¥çš®ãããéèŠã§ãããšå±ãç¶ããŠããã
ã¯ã¯ãã³æè·æŽŸã®ãã«ã»ã²ã€ãããã¡ãŠãã§ãããCOVID-19ã¯ã¯ãã³ã®æ§èœãäœãããšãèªããŠããã«ãããããããã§ããã
å æãCell Host and Microbeãèªã«çºè¡šãããè«æã®äžã§ããã¡ãŠããšåœŒã®å ±èè ã¯ãã€ã³ãã«ãšã³ã¶ãã³ãããŠã€ã«ã¹ãåŒåžåšåèäœãŠã€ã«ã¹ãRSVãããã³äžè¬çãªé¢šéªãå«ãäž»ã«ç²èåŒåžåšç³»ãŠã€ã«ã¹ããã仿¥ãŸã§èªå¯ã¯ã¯ãã³ãå®éšçã¯ã¯ãã³ã§å¹æçã«å¶åŸ¡ãããŠããªããããšã確èªããŸããã
圌ãã¯ããé«ãæ»äº¡çãæã€éå šèº«çãªç²èåŒåžåšãŠã€ã«ã¹ã«å¯Ÿããæç¶çãªé²åŸ¡ã¯ã¯ãã³ã¯ããããŸã§ã®ãšãããã¯ã¯ãã³éçºåªåããéããŠããŸããããšçµè«ä»ããŠããŸãã
ãã¹ã¯ãã©ã³ã»ããèªããèªç¶å ç«ã«é¢ãããããã®ç¥èŠãçºè¡šããããšã¯ãéåžžã«éèŠã§ããããèè ã®ãã¬ãŒãã³ã°ã¯ãã²ã€ããšãã¡ãŠãã®èªããããã«ããéãã«ãè¬çœªãªãã«ãçŸåšã®COVIDã¯ã¯ãã³ããé ããããæ°ããã¿ã€ãã®ã¯ã¯ãã³éçºã«ãã£ãšãéãå¿ èŠã§ãããšã»ã®ãããæå³ãããããšè¿°ã¹ãŠããŸãã誰ãééããç¯ããŠããªãã誰ã責任ãè² ããŸãããã¯ãªã¹ã»ããŒã¬ã€ã¯çªæåããªã詊ç®ã誀ãããšã¯ãªãã£ãããããããã ãéãéã£ãŠãç§ãã¡ã«ç§åŠãããããŠãã ãã"ã